Drive Clinical Trials

3 recruiting

Drive Trials at a Glance

10 actively recruiting trials for drive are listed on ClinicalTrialsFinder across 5 cities in 4 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Mumbai, Columbus, and Orange. Lead sponsors running drive studies include Tata Memorial Hospital, Ginger Yang, and Ganesh Babulal.

Browse drive trials by phase

Treatments under study

About Drive Clinical Trials

Looking for clinical trials for Drive? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Drive trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Drive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 3

Teen Driving Translation Study (NIH)

CommunicationDriveFeedback, Psychological+1 more
Ginger Yang580 enrolled1 locationNCT05696353
Recruiting
Phase 2

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Non-small Cell Lung CancerOligometastatic DiseaseDriver Mutation
Tata Memorial Hospital106 enrolled1 locationNCT05277844
Recruiting
Phase 3

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Asymptomatic Brain MetastasesDriver Mutation Positive Non-small Cell Lung Cancer
Tata Memorial Hospital190 enrolled1 locationNCT05236946
Recruiting
Not Applicable

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Lung CancerDriver Mutation
University of California, Irvine1,753 enrolled1 locationNCT07062172
Recruiting

Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems

Type 1 Diabetes MellitusType 1 Diabetes Mellitus With HypoglycemiaDrive
University Hospital, Motol120 enrolled1 locationNCT06382350
Recruiting

Depression and Driving

DepressionDrive
Ganesh Babulal150 enrolled1 locationNCT05446805
Recruiting

Investigating Driver Sleepiness and Crash Risk in Young Drivers: A Randomized Control Trial to Optimise Sleep

Driver sleepinessSleep loss
Institute for Social Science Research - University of Queensland210 enrolled1 locationACTRN12621000132842
Recruiting

DCD 1010 (PILOT STUDY): Validation Of A Spontaneous Breathing Test To Better Predict Time To Circulatory Death In Organ Donation Candidates (Safety And Feasibility Study)

Respiratory Drive
Dr Adelaide Charlton70 enrolled10 locationsACTRN12618000685213
Recruiting
Phase 2

The effect of methamphetamine and alcohol on cognition and driving performance.

Drugged drivers
Swinburne University of Technology30 enrolled1 locationACTRN12618000629235
Recruiting

P Drivers Project: the effects of a Driver Safety Behaviour Change Program on novice drivers

Crashes, infringements and self-reported driving behaviours among young novice drivers
VicRoads28,000 enrolled1 locationACTRN12612001232820